WASP_HUMAN - dbPTM
WASP_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID WASP_HUMAN
UniProt AC P42768
Protein Name Wiskott-Aldrich syndrome protein
Gene Name WAS
Organism Homo sapiens (Human).
Sequence Length 502
Subcellular Localization Cytoplasm, cytoskeleton.
Protein Description Effector protein for Rho-type GTPases. Regulates actin filament reorganization via its interaction with the Arp2/3 complex. Important for efficient actin polymerization. Possible regulator of lymphocyte and platelet function. Mediates actin filament reorganization and the formation of actin pedestals upon infection by pathogenic bacteria..
Protein Sequence MSGGPMGGRPGGRGAPAVQQNIPSTLLQDHENQRLFEMLGRKCLTLATAVVQLYLALPPGAEHWTKEHCGAVCFVKDNPQKSYFIRLYGLQAGRLLWEQELYSQLVYSTPTPFFHTFAGDDCQAGLNFADEDEAQAFRALVQEKIQKRNQRQSGDRRQLPPPPTPANEERRGGLPPLPLHPGGDQGGPPVGPLSLGLATVDIQNPDITSSRYRGLPAPGPSPADKKRSGKKKISKADIGAPSGFKHVSHVGWDPQNGFDVNNLDPDLRSLFSRAGISEAQLTDAETSKLIYDFIEDQGGLEAVRQEMRRQEPLPPPPPPSRGGNQLPRPPIVGGNKGRSGPLPPVPLGIAPPPPTPRGPPPPGRGGPPPPPPPATGRSGPLPPPPPGAGGPPMPPPPPPPPPPPSSGNGPAPPPLPPALVPAGGLAPGGGRGALLDQIRQGIQLNKTPGAPESSALQPPPQSSEGLVGALMHVMQKRSRAIHSSDEGEDQAGDEDEDDEWDD
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Phosphorylation------MSGGPMGGR
------CCCCCCCCC
53.0823401153
45PhosphorylationMLGRKCLTLATAVVQ
HHHHHHHHHHHHHHH
24.6620049867
54PhosphorylationATAVVQLYLALPPGA
HHHHHHHHHHCCCCC
3.4820049867
76SumoylationCGAVCFVKDNPQKSY
CCCEEEECCCCCCEE
31.38-
76UbiquitinationCGAVCFVKDNPQKSY
CCCEEEECCCCCCEE
31.38-
76SumoylationCGAVCFVKDNPQKSY
CCCEEEECCCCCCEE
31.38-
81UbiquitinationFVKDNPQKSYFIRLY
EECCCCCCEEEEEHH
48.67-
83PhosphorylationKDNPQKSYFIRLYGL
CCCCCCEEEEEHHHH
15.29-
88PhosphorylationKSYFIRLYGLQAGRL
CEEEEEHHHHHHHHH
13.1230257219
102PhosphorylationLLWEQELYSQLVYST
HHHHHHHHHHHHHCC
8.13-
144SumoylationFRALVQEKIQKRNQR
HHHHHHHHHHHHHHH
33.09-
144UbiquitinationFRALVQEKIQKRNQR
HHHHHHHHHHHHHHH
33.0921890473
144SumoylationFRALVQEKIQKRNQR
HHHHHHHHHHHHHHH
33.09-
147AcetylationLVQEKIQKRNQRQSG
HHHHHHHHHHHHHCC
57.7125953088
147SumoylationLVQEKIQKRNQRQSG
HHHHHHHHHHHHHCC
57.71-
147SumoylationLVQEKIQKRNQRQSG
HHHHHHHHHHHHHCC
57.71-
147UbiquitinationLVQEKIQKRNQRQSG
HHHHHHHHHHHHHCC
57.71-
194PhosphorylationGPPVGPLSLGLATVD
CCCCCCCEEEEEEEE
24.4329438985
210PhosphorylationQNPDITSSRYRGLPA
CCCCCCCCCCCCCCC
25.3629438985
212PhosphorylationPDITSSRYRGLPAPG
CCCCCCCCCCCCCCC
15.8127155012
221PhosphorylationGLPAPGPSPADKKRS
CCCCCCCCHHHHCCC
38.3423401153
234PhosphorylationRSGKKKISKADIGAP
CCCCCCCCHHHCCCC
30.5830108239
235UbiquitinationSGKKKISKADIGAPS
CCCCCCCHHHCCCCC
54.26-
277PhosphorylationLFSRAGISEAQLTDA
HHHHHCCCHHHCCCH
26.4328450419
282PhosphorylationGISEAQLTDAETSKL
CCCHHHCCCHHHHHH
22.5328450419
286PhosphorylationAQLTDAETSKLIYDF
HHCCCHHHHHHHHHH
32.6528450419
287PhosphorylationQLTDAETSKLIYDFI
HCCCHHHHHHHHHHH
19.5728450419
291PhosphorylationAETSKLIYDFIEDQG
HHHHHHHHHHHHHCC
18.4216472662
320PhosphorylationLPPPPPPSRGGNQLP
CCCCCCCCCCCCCCC
49.70-
321MethylationPPPPPPSRGGNQLPR
CCCCCCCCCCCCCCC
63.91115385621
328MethylationRGGNQLPRPPIVGGN
CCCCCCCCCCCCCCC
59.21115385627
338MethylationIVGGNKGRSGPLPPV
CCCCCCCCCCCCCCC
39.8052723715
339PhosphorylationVGGNKGRSGPLPPVP
CCCCCCCCCCCCCCC
54.1327080861
355PhosphorylationGIAPPPPTPRGPPPP
CCCCCCCCCCCCCCC
31.2427080861
357MethylationAPPPPTPRGPPPPGR
CCCCCCCCCCCCCCC
73.12115391857
357DimethylationAPPPPTPRGPPPPGR
CCCCCCCCCCCCCCC
73.12-
364MethylationRGPPPPGRGGPPPPP
CCCCCCCCCCCCCCC
53.3116287795
364DimethylationRGPPPPGRGGPPPPP
CCCCCCCCCCCCCCC
53.31-
377MethylationPPPPATGRSGPLPPP
CCCCCCCCCCCCCCC
33.80115391853
431MethylationGLAPGGGRGALLDQI
CCCCCCCHHHHHHHH
30.41115385633
439MethylationGALLDQIRQGIQLNK
HHHHHHHHHHHCCCC
24.04115385639
483PhosphorylationKRSRAIHSSDEGEDQ
HHHHHHHCCCCCCCC
33.1128674151
484PhosphorylationRSRAIHSSDEGEDQA
HHHHHHCCCCCCCCC
26.067753869

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
102YPhosphorylationKinaseNPM-ALKAAA58698
PSP
291YPhosphorylationKinaseNPM-ALKAAA58698
PSP
291YPhosphorylationKinaseABL1P00519
GPS
291YPhosphorylationKinaseTNK2Q07912
GPS
291YPhosphorylationKinaseBTKQ06187
PhosphoELM
291YPhosphorylationKinaseFYNP06241
Uniprot
291YPhosphorylationKinaseHCKP08631
Uniprot
291YPhosphorylationKinaseHCKP08103
PSP
291YPhosphorylationKinaseLCKP06239
PSP
291YPhosphorylationKinaseLYNP07948
PSP
483SPhosphorylationKinaseCSNK2A1P68400
GPS
483SPhosphorylationKinaseCK2-FAMILY-GPS
483SPhosphorylationKinaseCK2-Uniprot
484SPhosphorylationKinaseCSNK2A1P68400
GPS
484SPhosphorylationKinaseCK2-FAMILY-GPS
484SPhosphorylationKinaseCK2-Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of WASP_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of WASP_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
FYN_HUMANFYNphysical
8805332
GRB2_HUMANGRB2physical
9307968
EGFR_HUMANEGFRphysical
9307968
FYN_HUMANFYNphysical
10532312
VASP_HUMANVASPphysical
11598004
WIPF1_HUMANWIPF1physical
9405671
FYB1_HUMANFYBphysical
10747096
NCK1_HUMANNCK1physical
10747096
LCP2_HUMANLCP2physical
10747096
CDC42_HUMANCDC42physical
10724160
WIPF2_HUMANWIPF2physical
12213210
RAC1_HUMANRAC1physical
8643625
CDC42_HUMANCDC42physical
8643625
FYN_HUMANFYNphysical
7565724
FGR_HUMANFGRphysical
7565724
NCK1_HUMANNCK1physical
7565724
ITSN2_HUMANITSN2physical
11748279
CDC42_HUMANCDC42physical
8625410
RBBP5_HUMANRBBP5physical
20574068
JMJD6_HUMANJMJD6physical
20574068
KDM4A_HUMANKDM4Aphysical
20574068
KDM6B_HUMANKDM6Bphysical
20574068
ARPC3_HUMANARPC3physical
12769847
ARPC4_HUMANARPC4physical
12769847
ACK1_HUMANTNK2physical
16257963
ARPC2_HUMANARPC2physical
11943145
CDC42_HUMANCDC42physical
15075243
CBL_HUMANCBLphysical
23684068
CBLB_HUMANCBLBphysical
23684068
WIPF2_HUMANWIPF2physical
21988832
WIPF1_HUMANWIPF1physical
21988832
FNBP1_HUMANFNBP1physical
16418535
NCK1_HUMANNCK1physical
24287595
NCK2_HUMANNCK2physical
24287595
WIPF1_HUMANWIPF1physical
25416956
NCK2_HUMANNCK2physical
25416956
SRBS2_HUMANSORBS2physical
25416956
APBP2_HUMANAPPBP2physical
25416956
ABI3_HUMANABI3physical
25416956
CIP4_HUMANTRIP10physical
21516116
GAS7_HUMANGAS7physical
26506240
SAE1_HUMANSAE1physical
26261240
SAE2_HUMANUBA2physical
26261240
UBC9_HUMANUBE2Iphysical
26261240
RBP2_HUMANRANBP2physical
26261240
TF65_HUMANRELAphysical
26261240
ALDOA_RABITALDOAphysical
20129922
CDC42_HUMANCDC42physical
28539360

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
301000Wiskott-Aldrich syndrome (WAS)
313900Thrombocytopenia 1 (THC1)
300299Neutropenia, severe congenital, X-linked (XLN)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of WASP_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-291; SER-483 ANDSER-484, AND MASS SPECTROMETRY.
"Phosphoproteome of resting human platelets.";
Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.;
J. Proteome Res. 7:526-534(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-291; SER-483 ANDSER-484, AND MASS SPECTROMETRY.
"Phosphorylation of the WASP-VCA domain increases its affinity for theArp2/3 complex and enhances actin polymerization by WASP.";
Cory G.O.C., Cramer R., Blanchoin L., Ridley A.J.;
Mol. Cell 11:1229-1239(2003).
Cited for: PHOSPHORYLATION AT SER-483 AND SER-484, AND INTERACTION WITH THEARP2/3 COMPLEX.
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-291, AND MASSSPECTROMETRY.
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells.";
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.;
Nat. Biotechnol. 23:94-101(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-291, AND MASSSPECTROMETRY.
"Fyn and PTP-PEST-mediated regulation of Wiskott-Aldrich syndromeprotein (WASp) tyrosine phosphorylation is required for coupling Tcell antigen receptor engagement to WASp effector function and T cellactivation.";
Badour K., Zhang J., Shi F., Leng Y., Collins M., Siminovitch K.A.;
J. Exp. Med. 199:99-112(2004).
Cited for: PHOSPHORYLATION AT TYR-291 BY FYN.
"Phosphorylation of tyrosine 291 enhances the ability of WASp tostimulate actin polymerization and filopodium formation. Wiskott-Aldrich Syndrome protein.";
Cory G.O., Garg R., Cramer R., Ridley A.J.;
J. Biol. Chem. 277:45115-45121(2002).
Cited for: FUNCTION, PHOSPHORYLATION AT TYR-291 BY HCK, MASS SPECTROMETRY, ANDINTERACTION WITH HCK.

TOP